| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.07B | 21.06B | 20.90B | 19.99B | 19.60B | 17.43B |
| Gross Profit | 5.52B | 5.98B | 5.51B | 5.50B | 4.50B | 4.13B |
| EBITDA | 2.44B | 2.92B | 2.44B | 2.59B | 1.80B | 1.72B |
| Net Income | 888.00M | 2.78B | 1.02B | 1.16B | 504.00M | 462.00M |
Balance Sheet | ||||||
| Total Assets | 23.27B | 19.55B | 22.47B | 20.26B | 18.35B | 17.22B |
| Cash, Cash Equivalents and Short-Term Investments | 1.70B | 2.04B | 1.70B | 1.71B | 1.30B | 1.28B |
| Total Debt | 5.68B | 3.68B | 5.64B | 5.21B | 6.07B | 7.41B |
| Total Liabilities | 14.67B | 8.38B | 13.96B | 12.75B | 13.15B | 12.54B |
| Stockholders Equity | 8.49B | 11.05B | 8.40B | 7.42B | 5.13B | 4.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.51B | -1.85B | 587.00M | 152.00M | 392.00M |
| Operating Cash Flow | 0.00 | -259.00M | 181.00M | 2.65B | 1.77B | 1.59B |
| Investing Cash Flow | 0.00 | 2.87B | -490.00M | -1.94B | -371.00M | -614.00M |
| Financing Cash Flow | 0.00 | -2.31B | 243.00M | -327.00M | -1.40B | -858.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥9.75B | 2.97 | ― | 1.96% | 0.78% | 171.25% | |
68 Neutral | ¥6.87B | 7.90 | ― | 1.93% | 18.15% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ¥7.77B | 27.07 | ― | 2.97% | 2.12% | -64.98% | |
57 Neutral | ¥9.43B | 12.55 | ― | 2.98% | 11.18% | 3.78% | |
43 Neutral | ¥10.12B | 32.41 | ― | 1.06% | -7.88% | 129.32% |